Federated Hermes’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.49K | Buy |
+261
| New | +$8.49K | ﹤0.01% | 1837 |
|
|
2025
Q1 | – | Sell |
-326,058
| Closed | -$26.7M | – | 2169 |
|
|
2024
Q4 | $26.7M | Sell |
326,058
-174,992
| -35% | -$14.3M | 0.06% | 351 |
|
|
2024
Q3 | $57.3M | Buy |
501,050
+75,410
| +18% | +$8.62M | 0.13% | 212 |
|
|
2024
Q2 | $32.1M | Sell |
425,640
-110
| -0% | -$8.31K | 0.08% | 293 |
|
|
2024
Q1 | $29.1M | Buy |
425,750
+31,558
| +8% | +$2.16M | 0.07% | 336 |
|
|
2023
Q4 | $24.8M | Sell |
394,192
-1,615
| -0.4% | -$101K | 0.06% | 341 |
|
|
2023
Q3 | $20.2M | Sell |
395,807
-627
| -0.2% | -$32K | 0.05% | 365 |
|
|
2023
Q2 | $19.8M | Buy |
396,434
+319,521
| +415% | +$16M | 0.05% | 390 |
|
|
2023
Q1 | $2.88M | Buy |
76,913
+76,694
| +35,020% | +$2.87M | 0.01% | 842 |
|
|
2022
Q4 | $10.5K | Buy |
+219
| New | +$10.5K | ﹤0.01% | 1860 |
|